Masimo Corporation $MASI Stake Lowered by Alpha Wave Global LP

Alpha Wave Global LP lessened its stake in Masimo Corporation (NASDAQ:MASI) by 4.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,102 shares of the medical equipment provider’s stock after selling 4,966 shares during the quarter. Masimo accounts for approximately 1.5% of Alpha Wave Global LP’s holdings, making the stock its 8th biggest position. Alpha Wave Global LP owned approximately 0.18% of Masimo worth $14,327,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. MAI Capital Management lifted its holdings in shares of Masimo by 176.7% during the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 129 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in Masimo by 80.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 136 shares in the last quarter. Allworth Financial LP raised its position in Masimo by 72.8% in the 2nd quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock worth $65,000 after buying an additional 163 shares during the last quarter. Clearstead Advisors LLC lifted its stake in Masimo by 18.4% during the 3rd quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock valued at $69,000 after acquiring an additional 73 shares during the period. Finally, Hantz Financial Services Inc. lifted its stake in Masimo by 792.3% during the 3rd quarter. Hantz Financial Services Inc. now owns 580 shares of the medical equipment provider’s stock valued at $86,000 after acquiring an additional 515 shares during the period. Institutional investors own 85.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Wells Fargo & Company lowered shares of Masimo from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $190.00 to $180.00 in a research note on Wednesday, February 18th. Bank of America initiated coverage on Masimo in a report on Monday, November 17th. They issued a “neutral” rating and a $162.00 price objective for the company. BTIG Research cut Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a report on Thursday, January 22nd. Finally, Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. One investment analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $181.17.

Masimo Price Performance

Shares of MASI stock opened at $175.49 on Friday. The stock has a 50 day moving average price of $151.80 and a 200 day moving average price of $145.86. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $175.90. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. The firm has a market capitalization of $9.43 billion, a P/E ratio of -16.65, a P/E/G ratio of 1.78 and a beta of 1.21.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.